Daniel Reed is a regulatory affairs and intelligence leader with over 10 years of experience in strategic planning, policy analysis, and intelligence strategy. Currently, they serve as the Head of Regulatory Affairs Intelligence at Novartis, where they lead the regulatory intelligence organization and collaborate with senior leaders to implement impactful strategies. Daniel previously contributed to global regulatory intelligence and policy strategy at AstraZeneca, focusing on cardio-renal disease and advanced therapies. They are recognized for driving insights in regulatory intelligence and fostering collaboration, enabling informed decision-making through strategic intelligence and the integration of AI. Daniel holds a Doctor of Philosophy (PhD) in Cardiothoracic Pharmacology from Imperial College London.
This person is not in the org chart
This person is not in any teams
This person is not in any offices